Springer Nature
Browse
41100_2019_221_MOESM1_ESM.docx (43.06 kB)

Additional file 1: of Long-term safety and effectiveness of a continuous erythropoietin receptor activator (CERA) in patients with renal anemia: a prospective, observational, multicenter study

Download (43.06 kB)
journal contribution
posted on 2019-06-06, 05:00 authored by Hidehiro Tabata, Hiroyuki Kanno, Ayako Murayama, Tadashi Ishii, Ryosuke Harada, Yukio Udagawa
ADRs leading to death. This table gives demographic and clinical characteristics of patients with an ADR whose outcome was death, and includes relevant details relating to their death. (DOCX 43 kb)

Funding

Chugai Pharmaceutical Co., Ltd.

History

Usage metrics

    Renal Replacement Therapy

    Categories

    Keywords

    Chronic kidney diseaseContinuous erythropoietin receptor activatorDialysisMethoxy polyethylene glycol-epoetin betaAnemia

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC